Abstract PS5-07-10: Young HOPE/JCOG2402: A Randomized Phase III Study of Response-Guided Therapy Following Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer
Abstract PS5-07-10: Young HOPE/JCOG2402: A Randomized Phase III Study of Response-Guided Therapy Following Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer
Keita Sasaki, Taro Shibata, Noriko Mitome, Takahiro Tsukioki et al.
Journal
Clinical Cancer Research
Topics
Breast Cancer Treatment Studies
article
Abstract PS5-07-10: Young HOPE/JCOG2402: A Randomized Phase III Study of Response-Guided Therapy Following Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer
Keita Sasaki, Taro Shibata, Noriko Mitome, Takahiro Tsukioki, Ikuno Nishibuchi, Natsue Uehiro, Yuko Tanabe, Yumiko Koi, Yoichi Naito, F. Hara, H. Iwata, H. Tsuda, M. Kawamura, M. Yoshida, Y. Kikawa, M. Ono, T. Fujisawa, Y. Sagara, T. Shien
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical Cancer ResearchVol. 32(4_Supplement)
Institutions
Kansai Medical University (JP), Nagoya City University (JP), National Cancer Center (US), Nagoya University Hospital (JP), National Hospital Organization Kyushu Cancer Center (JP), Okayama University Hospital (JP), Breast Center (CH), Kagoshima City Hospital (JP), Hiroshima University Hospital (JP), Gunma Prefectural Cardiovascular Center (JP), Teikyo University Chiba Medical Center (JP), Aichi Cancer Center (JP), The Cancer Institute Hospital (JP), National Cancer Center Hospital East (JP), Gunma Children's Medical Center (JP), Japan Clinical Cancer Research Organization (JP), Tokyo National Hospital (JP), Toranomon Hospital (JP)